10.1542/peds.2013-2215 149
Patients and caregivers should understand that while research into GLP-1 medications and Alzheimer's disease is promising, these drugs are not currently approved or recommended specifically for dementia prevention or treatment
J., Coskun, T., Thomas, M
A medical provider should determine whether a patient meets appropriate criteria and whether the medication is suitable considering medical history, current medications, potential risks, and treatment goals
In addition, lessons learned from type 2 diabetes with regard to the beneficial effects of certain agents on, for example, body weight and cardiorenal risk may also prove relevant in type 1 diabetes
Do not stop semaglutide without discussing with your prescriber